Immunovant, Inc. Share Price
IMVT$0.00
+0.00 (0.00%) Immunovant, Inc. Stock Performance
Open N/A | Prev. Close N/A | Circuit Range N/A |
Day Range N/A | Year Range N/A | Volume N/A |
Average Traded N/A |
Immunovant, Inc. Share Price Chart
$0.00
Please wait...
About Immunovant, Inc.
Immunovant, Inc., a clinical-stage immunology company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops IMVT-1402 for graves' disease, rheumatoid arthritis, myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, cutaneous lupus erythematosus disease, and sjögren's disease; and batoclimab for graves' disease and thyroid eye disease. The company has a license agreement with HanAll Biopharma Co., Ltd. for the rights of intellectual property relating to IMVT-1402 and batoclimab. Immunovant, Inc. was founded in 2018 and is based in New York, New York. Immunovant, Inc. is a subsidiary of Roivant Sciences Ltd.
Immunovant, Inc. Historical Data
| Day | Open | Close | Change % |
|---|
FAQs on Immunovant, Inc. Share Price
Can I buy Immunovant, Inc. shares in India?
Yes. You can buy Immunovant, Inc. in India by opening an international trading account.
What is the share price of Immunovant, Inc.?
As on 08 Feb '26, the share price of Immunovant, Inc. IMVT is $0.00. If you are investing from India, it is a good idea to check the current exchange rate and calculate the value in rupees before making your investment.
What is the 5 year returns of Immunovant, Inc.?
The 5 year returns of Immunovant, Inc. is as on 08 Feb '26.
What are the high & low stock price of Immunovant, Inc. today?
Immunovant, Inc. stock price hit a high of $0.00 and low of $0.00 as on 08 Feb '26.
What is the 52-week high and low of Immunovant, Inc. stock?
The 52-week high of Immunovant, Inc. stock is $0.00, while the 52-week low is $0.00 as on 08 Feb '26.